Connection

Daniel Watterson to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications Daniel Watterson has written about Antibodies, Neutralizing.
Daniel Watterson
Connection Strength
0.105
Antibodies, Neutralizing
  1. Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody. Sci Rep. 2021 02 08; 11(1):3318.
    View in: PubMed
    Score: 0.033
  2. Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion. J Gen Virol. 2021 01; 102(1).
    View in: PubMed
    Score: 0.032
  3. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope. Structure. 2018 01 02; 26(1):51-59.e4.
    View in: PubMed
    Score: 0.026
  4. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
    View in: PubMed
    Score: 0.008
  5. Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG. Sci Rep. 2017 02 03; 7:41537.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.